Search results

Responding to the announcement that COVAX has received more funding and is planning to accelerate its vaccine rollout, Oxfam International’s Head of Inequality Policy, Max Lawson, said: “More funding for COVAX and a quicker rollout of vaccines is a small piece of good news for developing countries struggling to get the doses they need, but at best fewer than a quarter of people in these countries will have been vaccinated by the end of the year."

In response to the announcement today from French President, Emmanuel Macron, that France will support a temporary waiver on intellectual property for COVID-19 vaccines, tests and treatments, Oxfam’s Health Policy Manager, Anna Marriott, said: “It is fantastic news that President Macron has joined US President Biden on the right side of history by supporting the calls from India and South Africa, as well as millions of people around the world."

Nearly 70 poor countries will only be able to vaccinate one in ten people against COVID-19 next year unless urgent action is taken by governments and the pharmaceutical industry to make sure enough doses are produced.

Survivors of COVID-19 from 37 countries are among almost 1,000 people who have signed an open letter to pharmaceutical industry leaders calling for a ‘people's vaccine’ and treatments that are available to all – free from patents. The letter comes on the eve of a high-level side event about the pandemic at the UN General Assembly in New York.

Millions of women and men who produce our food are trapped in poverty and face brutal working conditions, despite billion-dollar profits in the food industry, reveals a new report published by Oxfam.   

Major European supermarkets have upped their dividend payouts to shareholders by an average of 123 percent during the first eight months of the pandemic. Shockingly, hardly any of these supermarkets paid any substantial COVID-19-related support to the workers and farmers who throughout the crisis kept supply chains going.